Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
American Journal of Clinical Dermatology
Erschienen in: American Journal of Clinical Dermatology 5/2000

01.09.2000 | Review Article

Management of Oral Lichen Planus

verfasst von: Professor Crispian Scully, Drore Eisen, Marco Carrozzo

Erschienen in: American Journal of Clinical Dermatology | Ausgabe 5/2000

Einloggen, um Zugang zu erhalten

Abstract

Lichen planus is a relatively common disorder of the stratified squamous epithelia. Most dental and medical practitioners see patients with lichen planus, but not all are recognized as having the disease. Patients with lichen planus may have concomitant involvement of the disease in multiple sites. Oral lichen planus lesions usually have a distinctive clinical morphology and characteristic distribution, but oral lichen planus may also present a confusing array of patterns and forms, and other disorders may clinically mimic oral lichen planus.
The etiopathogenesis of lichen planus appears to be complex, with interactions between genetic, environmental, and lifestyle factors. Much has now been clarified about the etiopathogenic mechanisms involved and interesting new associations, such as with liver disease, have emerged.
The management of lichen planus is still not totally satisfactory in all cases and there is as yet no definitive treatment that results in long term remission, but there have been advances in the control of the condition. Amongst the many treatments available, high potency topical corticosteroids remain the most reliably effective, though topical cyclosporine, topical tacrolimus, or systemic corticosteroids may be indicated in patients whose condition is unresponsive to topical corticosteroids.
Literatur
1.
Scully C., El-kom M. Lichen planus: review and update in pathogenesis. J Oral Pathol Med 1985; 14: 431–438CrossRef
2.
Duske J.J., Frick W.G. Lichen planus — oral manifestations and suggested treatments. J Oral Maxillofac Surg 1982; 40: 240–244CrossRef
3.
Conklin R.J., Blasberg B. Oral lichen planus. Dermatol Clin 1987; 5: 663–673PubMed
4.
5.
Eisen D. The evaluation of cutaneous, genital, scalp, nail, esophageal and ocular involvement in patients with oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 88: 431–436PubMedCrossRef
6.
Scully C., Beyli M., Ferreiro M.C., et al. Update on oral lichen planus: etiopathogenesis and management. Crit Rev Oral Biol Med 1998; 9: 86–122PubMedCrossRef
7.
Thorn J.J., Holmstrup P., Rindrum J., et al. Course of various clinical forms of oral lichen planus. A prospective follow-up study of 611 patients. J Oral Pathol 1988; 17: 213–218PubMedCrossRef
8.
Lozada-Nur F., Miranda C. Oral lichen planus: topical and systemic therapy. Semin Cutan Med Surg 1997; 16: 295–300PubMedCrossRef
9.
Silverman S Jr, Bahl S. Oral lichen planus update: clinical characteristics, treatment responses, and malignant transformation. Am J Dent 1997; 10: 259–263PubMed
10.
Siegel M.A. Strategies for management of commonly encountered oral mucosal disorders. J Calif Dent Assoc 1999; 27: 210–212, 215, 218-9PubMed
11.
Popovsky J.L., Camisa C. New and emerging therapies for diseases of the oral cavity. Dermatol Clin 2000; 18: 113–125PubMed
12.
McCreary C.E., McCartan B.E. Clinical management of oral lichen planus. Br J Oral Maxillofac Surg 1999; 37: 338–343PubMedCrossRef
13.
Bernstein M.L. The diagnosis and management of chronic nonspecific mucosal lesions. J Calif Dent Assoc 1999; 27: 290–299PubMed
14.
15.
Miles D.A., Howard M.M. Diagnosis and management of oral lichen planus. Dermatol Clin 1996; 14: 281–290PubMedCrossRef
16.
Scully C., Porter S.R. The clinical spectrum of desquamative gingivitis. Semin Cutan Med Surg 1997; 16: 308–313PubMedCrossRef
17.
Axell T., Rundquist L. Oral lichen planus — a demographic study. Community Dent Oral Epidemiol 1987; 15: 52–66PubMedCrossRef
18.
Bagan J.V., Milian-Masanet M.A., Penarrocha-Diago M., et al. A clinical study of 205 patients with oral lichen planus. J Oral Maxillofac Surg 1992; 50: 116–118CrossRef
19.
Holmstrup P., Dalbelsteen E. The frequency of Candida in oral lichen planus. Scand J Dent Res 1974; 82: 584–587PubMed
20.
Lundstrom I.M.C., Anneroth G.B., Holmberg K. Candida in patients with oral lichen planus. Int J Oral Surg 1984; 13: 226–238PubMedCrossRef
21.
Krogh P., Holmstrup P., Thorn J.J., et al. Yeast species and biotypes associated with oral leukoplakia and lichen planus. Oral Surg Oral Med Oral Pathol 1987; 63: 48–54PubMedCrossRef
22.
Simon M. Jr, Hornstein O.P. Prevalence rate of Candida in the oral cavity of patients with oral lichen planus. Arch Dermatol Res 1980; 267: 317–318PubMedCrossRef
23.
Dreyer W.P. The clinical manifestations of oral lichen planus. J Dent Assoc S Afr 1983; 38: 619–624PubMed
24.
Lacy M.F., Reade P.C., Hay K.D., Lichen planus: a theory of pathogenesis. Oral Surg Oral Med Oral Pathol 1983; 56: 521–526PubMedCrossRef
25.
Hatchuel D.A., Peters E., Lemmer J., et al. Candidal infection in oral lichen planus. Oral Surg Oral Med Oral Pathol 1990; 70: 172–175PubMedCrossRef
26.
Vincent S.D., Fotos P.G., Baker K.A., et al. Oral lichen planus: the clinical, historical and therapeutic features of 100 cases. Oral Surg Oral Med Oral Pathol 1990; 70: 165–171PubMedCrossRef
27.
Albrecht M., Banoczy J., Dinya E., et al. Occurrence of oral leukoplakia and lichen planus in diabetes mellitus. J Oral Pathol Med 1992; 21: 364–366PubMedCrossRef
28.
Ostman P.-O., Anneroth G., Skoglund A., Oral lichen planus lesions in contact with amalgam fillings: a clinical, histologic and immunohistochemical study. Scand J Dent Res 1994; 102: 172–179PubMed
29.
Serra R., Carrozzo M., Conrotto D., et al. Significato prognostico della colonizzazione da Candida di lesioni del cavo orale. Microbiol Med 1996; 11: 228–232
30.
Barrett A.W., Kingsmill V.J., Speight P.M., The frequency of fungal infection in biopsies of oral mucosal lesions. Oral Dis 1998; 4: 26–31PubMedCrossRef
31.
Carbone M., Conrotto D., Carrozzo M., et al. Topical corticosteroids in association with miconazole and chlorhexidine in the long-term management of atrophicerosive oral lichen planus: a placebo-controlled and comparative study between clobetasol and fluocinonide. Oral Dis 1999; 5: 44–49PubMedCrossRef
32.
Barnard N.A., Scully C., Eveson J.W., et al. Oral cancer development in patients with oral lichen planus. J Oral Pathol Med 1993; 22: 421–424PubMedCrossRef
33.
Krutchkoff D.J., Cutler L., Laskowski S., Oral lichen planus: the evidence regarding potential malignant transformation. J Oral Pathol 1978; 7: 1–7PubMedCrossRef
34.
Krutchkoff D.J., Eisenberg E., Lichenoid dysplasia: a distinct histopathologic entity. Oral Surg Oral Med Oral Pathol 1985; 60: 308–315PubMedCrossRef
35.
Eisenberg E., Krutchkoff D.J., Lichenoid lesions of oral mucosa. Diagnostic criteria and their importance in the alleged relationship to oral cancer. Oral Surg Oral Med Oral Pathol 1992; 73: 699–704PubMedCrossRef
36.
Holmstrup P. The controversy of a premalignant potential of oral lichen planus is over. Oral Surg Oral Med Oral Pathol 1992; 73: 704–706PubMedCrossRef
37.
Kovesi G., Banoczy J. Follow-up studies in oral lichen planus. Int J Oral Surg 1973; 2: 13–19PubMedCrossRef
38.
Silverman S Jr, Griffith M. Studies on oral lichen planus. II. Follow-up on 200 patients, clinical characteristics, and associated malignancy. Oral Surg Oral Med Oral Pathol 1974; 37: 705–710PubMedCrossRef
39.
Murti P.R., Daftary D.K., Bhonsie R.B., et al. Malignant potential of oral lichen planus: observation in 722 patients from India. J Oral Pathol 1986; 15: 71–77PubMedCrossRef
40.
Holmstrup P., Thorn J.J., Rindrum J., et al. Malignant development of lichen planus- affected oral mucosa. J Oral Pathol 1988; 17: 219–225PubMedCrossRef
41.
Herrmann D. Karzinomentstehung bei oralem Lichen planus. Langzeituntersuchung an 919 Patienten. Dtsch Zahnartztl Z 1992; 47: 877–879
42.
Fulling H.J.. Cancer development in oral lichen planus: a follow-up study of 327 patients. Arch Dermatol 1973; 108: 667–669PubMedCrossRef
43.
Voute A.B., De Jong W.F., Schulten E.A.J., et al. Possible premalignant character of oral lichen planus. The Amsterdam experience. J Oral Pathol Med 1992; 21: 326–329PubMedCrossRef
44.
Silverman S Jr, Gorsky M., Lozada-Nur F. A prospective follow-up study of 570 patients with oral lichen planus: persistence, remission and malignant association. Oral Surg Oral Med Oral Pathol 1985; 60: 30–34PubMedCrossRef
45.
Silverman S Jr, Gorsky M., Lozada-Nur F., et al. A prospective study of findings and management in 214 patients with oral lichen planus. Oral Surg Oral Med Oral Pathol 1991; 72: 665–670PubMedCrossRef
46.
MacDonald D.G., Rennie J.S. Oral epithelial atypia in denture-induced hyperplasia, lichen planus and squamous cell papilloma. Int J Oral Surg 1975; 4: 40–45PubMedCrossRef
47.
Holmstrup P., Pindborg J.J. Erythroplakic lesions in relation to oral lichen planus. Acta Dermatol (Stockh) 1979; 59 Suppl.: 77–84
48.
Kaugars G.E., Svirsky J.A. An update on the dysplastic/carcinomatous transformation of oral lichen planus. J Oral Med 1982; 37: 75–79PubMed
49.
De Jong W.F., Albrecht M., Banoczy J., et al. Epithelial dysplasia in oral lichen planus. A preliminary report of a Dutch-Hungarian study of 100 cases. Int J Oral Surg 1984; 13: 221–225PubMedCrossRef
50.
Pindborg J.J., Reibel J., Holmstrup P. Subjectivity in evaluating oral epithelial dysplasia, carcinoma in situ and initial carcinoma. J Oral Pathol 1985; 14: 698–708PubMedCrossRef
51.
Van Der Meij E.H., Schepman K.P., Smeele L.E., et al. A review of the recent literature regarding malignant transformation of oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 88 (3) 307–310PubMedCrossRef
52.
Kilpil P.I., Rich A.M., Konttinen Y.T., et al. The expression of c-erb-B-2 protein in the keratinocytes of oral mucosal lichen planus. Br J Derm 1995; 133: 847–852CrossRef
53.
Jepsen H., Winther J.E. Mycotic infection in oral leukoplakia. Acta Odontol Scand 1965; 23: 239–256PubMedCrossRef
54.
Renstrup G. Occurrence of Candida in oral leukoplakias. Acta Pathol Microbiol Scand Sect B 1970; 78: 421–424
55.
Cawson R.A., Binnie W.H. Candida leukoplakia and carcinoma — a possible relationship. In: Dabelsteen E., MacKenzie I.C., Squier C.A., editors. Oral premalignancy. Iowa: University of Iowa Press, 1977: 59–66
56.
Cox M., Maitland N., Scully C. Human herpes simplex-1 and papillomavirus type 16 homologous DNA sequences in normal, potentially malignant and malignant oral mucosa. Oral Oncol 1993; 29B: 215–219
57.
Walsh L.J., Savage N.W., Ishi T., et al. Immunopathogenesis of oral lichen planus. J Oral Pathol Med 1990; 19: 389–396PubMedCrossRef
58.
Barker J.N.W.N., Mitra R.S., Griffiths C.E.M., et al. Keratinocytes as indicators of inflammation. Lancet 1991; 337: 211–214PubMedCrossRef
59.
Hietanen J., Pihlman K., Forstrom L., et al. No evidence of hypersensitivity to dental restorative metals in oral lichen planus. Scand J Dent Res 1987; 95: 320–327PubMed
60.
Holmstrup P. Reactions of the oral mucosa related to silver amalgam. J Oral Pathol Med 1991; 20: 1–7PubMedCrossRef
61.
Lundstrom I.M.C. Allergy and corrosion of dental materials in patients with oral lichen planus. Int J Oral Surg 1984; 13: 16–24PubMedCrossRef
62.
Lind P.O., Hurlen B., Lyberg T., et al. Amalgam-related oral lichenoid reaction. Scand J Dent Res 1986; 94: 448–451PubMed
63.
Bolewska J., Hansen H.J., Holmstrup P., et al. Oral mucosal lesions related to silver amalgam restorations. Oral Surg Oral Med Oral Pathol 1990; 70: 55–58PubMedCrossRef
64.
Finne K., Goransson K., Winkler L. Oral lichen planus and contact allergy to mercury. Int J Oral Surg 1982; 11: 236–239PubMedCrossRef
65.
Jolly M., Moule A.J., Bryant R.W., et al. Amalgam related chronic ulceration of oral mucosa. Br Dent J 1986; 160: 434–437PubMedCrossRef
66.
Skoglund A., Egelrud T. Hypersensitivity reactions to dental materials in patients with lichenoid oral mucosal lesions and in patients with burning mouth syndrome. Scand J Dent Res 1991; 99: 320–328PubMed
67.
Laine J., Kalimo K., Forssell H., et al. Resolution of oral lichenoid lesions after replacement of amalgam restorations in patients allergic to mercury compounds. Br J Dermatol 1992; 126: 10–15PubMedCrossRef
68.
Jameson M.W., Kardos T.B., Kirk E.E., et al. Mucosal reactions to amalgam restorations. J Oral Rehab 1990; 17: 293–301CrossRef
69.
Bircher A.J., Von Schultness A., Henning G. Oral lichenoid lesions and mercury sensitivity. Contact Dermatitis 1993; 29: 275PubMedCrossRef
70.
Skoglund A. Value of epicutaneous patch testing in patients with oral mucosal lesions of lichenoid character. Scand J Dent Res 1994; 102: 216–222PubMed
71.
Henriksson E., Mattsson U., Hakansson J. Healing of lichenoid reactions following removal of amalgam. J Clin Periodontol 1995; 22: 287–284PubMedCrossRef
72.
Smart E.R., Macleod R.I., Lawerence C.M. Resolution of lichen planus following removal of amalgam restorations in patients with proven allergy to mercury salts: a pilot study. Br Dent J 1995; 178: 108–112PubMedCrossRef
73.
Bratel J., Hakeberg M., Jontell M., Effect of replacement of dental amalgam on oral lichenoid reactions. J Dent 1996; 24: 41–45PubMedCrossRef
74.
Ibbotson S.H., Speight E.L., Macleod R.I., et al. The relevance and effect of amalgam replacement in subjects with oral lichenoid reactions. Br J Dermatol 1996; 134: 420–423PubMedCrossRef
75.
Eversole L.R., Ringer M. The role of restorative metals in the pathogenesis of oral lichen planus. Oral Surg Oral Med Oral Pathol 1984; 57: 383–387PubMedCrossRef
76.
Mobacken H., Hersle K., Sloberg K., et al. Oral lichen planus: hypersensitivity to dental restoration material. Contact Dermatol 1984; 10: 11–15CrossRef
77.
James J., Ferguson M.M., Forstyth A., et al. Oral lichenoid reactions related to mercury sensitivity. Br J Oral Maxillofac Surg 1987; 25: 474–480PubMedCrossRef
78.
Axell T., Specihowitz E., Glantz P.O., et al. A new method for intraoral patch-testing. Contact Dermatitis 1986; 15: 58–62PubMedCrossRef
79.
Fryholm K.O., Frithiofi L., Fernstron A., et al. Allergy to copper derived from dental alloys as a possible cause of oral lesions of lichen planus. Acta Derm Venereol 1969; 49: 268–281
80.
Banoczy J., Roed-Peterson B., Pindborg J. Clinical and histologic studies on electrogalvanically induced oral white lesions. Oral Surg Oral Med Oral Pathol 1979; 48: 319–328PubMedCrossRef
81.
Holland R. Galvanic currents between gold and amalgam. Scand J Dent Res 1980; 988: 269–272
82.
Torresani C., Nannini R., Bondi A., et al. Erosive lichen planus due to sensitization to cobalt chloride. Clin Exp Dermatol 1994; 19: 535–536PubMedCrossRef
83.
Lind P. Oral lichenoid reactions related to composite restorations. Acta Odontol Scand 1988; 46: 63–65PubMedCrossRef
84.
Blomgren J., Axell T., Sandahl O., et al. Adverse reactions in the oral mucosa associated with anterior composite restorations. J Oral Pathol Med 1996; 25: 311–313PubMedCrossRef
85.
Savage J. Lichenoid dermatitis due to chloroquine. J Dermatol 1958; 70: 181CrossRef
86.
Penneys N.S., Ackerman A.B., Gottlieb N.L. Gold dermatitis. Arch Dermatol 1974; 109: 372–376PubMedCrossRef
87.
Hakala S., Van Assendelf A.H.W., Illonen J., et al. Association of different HLA antigens with various toxic effects of gold salts in rheumatic arthritis. Ann Rheum Dis 1986; 48: 177–182CrossRef
88.
Brown R.S., Hays G.L., Flaitz C.M. Treatment of gold salt-induced oral lichen planus: report of a case. Cutis 1993; 51: 183–185PubMed
89.
Laeijendecker R., Van Joost T.H. Oral manifestations of gold allergy. J Am Acad Dermatol 1994; 30: 205–209PubMedCrossRef
90.
Potts A.J.C., Hamburger J., Scully C. The medication of patients with oral lichen planu s and the association of nonsteroidal anti-inflammatory drugs with erosivelesions. Oral Surg Oral Med Oral Pathol 1987; 64: 541–543PubMedCrossRef
91.
Firth N.A., Reade P.C. Angiotensin-converting enzyme inhibitors implicated in oral mucosal lichenoid reactions. Oral Surg 1989; 67: 41–44PubMedCrossRef
92.
Robertson W.D., Wray D. Ingestion of medication among patients with oral keratoses including lichen planus. Oral Surg Oral Med Oral Pathol 1992; 74: 183–185PubMedCrossRef
93.
Van Dis M.L., Parks E.T. Prevalence of oral lichen planus in patients with diabetes mellitus. Oral Surg Oral Med Oral Pathol 1995; 79: 696–700CrossRef
94.
Shatin H., Canizares O., Worthington E.I. Lichen planus like drug eruption due to para-aminosalicylic acid. Report of 5 cases — two showing mouth lesions. J Invest Dermatol 1953; 21: 135–138PubMed
95.
Groth O. Lichenoid dermatitis resulting from treatment with the phenothiazine derivative metopromazine and laevopromazine. Acta Derm Venereol (Stockh) 1961; 41: 168–177
96.
Baker H., Hughes D.T.D., Pegum J.S. Lichenoid eruption due to amiphenazole. Br J Dermatol 1964; 76: 186–190PubMedCrossRef
97.
Dinsdale R.C.W., Ormerod T.P., Walker A.E. Amiphenazole sensitivity with oral ulceration. Br Dent J 1966; 121: 460–462PubMed
98.
99.
Chau N.Y., Reade P.C., Rich A.M., et al. Allopurinol-amplified lichenoid reactions of the oral mucosa. Oral Surg Oral Med Oral Pathol 1984; 58: 397–400PubMedCrossRef
100.
Hogan D.J., Murphy F., Burgess W.R., et al. Lichenoid stomatitis associated with lithium carbonate. J Am Acad Dermatol 1985; 13: 243–246PubMedCrossRef
101.
Colvard M.D., Nadimi H., Gargiulo A.V. Ativan (lorazepam) induced lichenoid reaction of the human attached gingiva: case report. Periodont Case Rep 1986; 8 69–70PubMed
102.
Markitziu A., Katz J., Pisanty S. Lichenoid lesions of oral mucosa associated with ketaconazole. Mykosen 1986; 29: 317–322PubMedCrossRef
103.
Torrelo A., Soria C., Rocamora A., et al. Lichen planus-like eruption with esophageal involvement as a result of cyanamide. J Am Acad Dermatol 1990; 23: 1168–1169PubMedCrossRef
104.
Wiesenfeld D., Scully C., Macfarlane E.E. Multiple lichenoid drug reactions in a patient with Ferguson-Smith disease. Oral Surg 1982; 54: 527–529PubMedCrossRef
105.
Downham T.F. Spironolactone-induced lichen planus. J Am Med Assoc 1978; 240: 1138CrossRef
106.
Kerby J.D., Black M., McGibbon T. Levamisole induced lichenoid eruptions. R Soc Med 1980; 73: 208
107.
Fitzpatrick T.B. Lichen planus-like drug eruption. Arch Dermatol 1963; 88: 352
108.
Lamey P.-J., McCartan B.E., MacDonald D.G., et al. Basal cell cytoplasmic autoantibodies in oral lichenoid reactions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995; 79: 44–49PubMedCrossRef
109.
Van Den Haute V., Antoine J.L., Lachapelle J.M. Histopathological discriminant criteria between lichenoid drug eruptions and idiopathic lichen planus: retrospective study on selected samples. Dermatologica 1989; 179: 10–13PubMedCrossRef
110.
Van Joost T. Incidence of circulating antibodies reactive with basal cells of skin in drug reactions. Acta Derm Venereol (Stockh) 1974; 54: 183–188
111.
Watanabe C., Hayashi T., Kawada A. Immunofluorescence study of drug-induced lichen planus-like lesions. J Dermatol 1981; 8: 473–477PubMed
112.
Gibson L.E., Van Hale H.M., Schroeter A.L. Direct immunofluorescence for the study of cutaneous drug eruptions. Acta Derm Venereol (Stockh) 1986; 66: 39–44
113.
Mcqueen A., Behan W.M.H. The ‘string of pearls’ phenomenon — an immunofluorescent serological finding in patients screened for adverse drug reactions. Am J Dermatopathol 1982; 4: 155–159PubMedCrossRef
114.
Eisen D. The therapy of oral lichen planus. Crit Rev Oral Biol Med 1993; 4: 141–158PubMed
115.
Yadav M., Arivananthan M., Chandrashekran A., et al. Human herpesvirus-6 (HHV-6) DNA and virus-encoded antigen in oral lesions. J Oral Pathol Med 1997; 26: 393–401PubMedCrossRef
116.
Ghodratnama F., Riggio M.P., Wray D. Search for human herpesvirus 6, human cytomegalovirus and varicella zoster virus DNA in recurrent aphthous stomatitis tissue. J Oral Pathol Med 1997; 26: 192–197PubMedCrossRef
117.
Leimola-Virtanen R., Happonen R.P., Syrjanen S. Cytomegalovirus (CMV) and Helicobacter pylori (HP) found in oral mucosal ulcers. J Oral Pathol Med 1995; 24: 14–17PubMedCrossRef
118.
Jontell M., Watts S., Wallstrom M., et al. Human papilloma virus in erosive oral lichen planus. J Oral Pathol Med 1990; 19: 273–277PubMedCrossRef
119.
Gonzalez-Moles M.A., Rodriguez-Archilla A., Ruiz Avila I., et al. Presence of HPV 16 sequences in oral lichen planus lesions. Bull Group Int Rech Sci Stomatol Odontol 1998; 40: 92–97PubMed
120.
121.
Boyd A.S., Annarella M., Rapini R.P., et al. False-positive polymerase chain reaction results for human papillomavirus in lichen planus. Potential laboratory pitfalls of this procedure. J Am Acad Dermatol 1996; 35: 42–46PubMedCrossRef
122.
Wen S., Tsuji T., Li X., et al. Detection and analysis of human papillomavirus 16 and 18 homologous DNA sequences in oral lesions. Anticancer Res 1997; 17: 307–311PubMed
123.
Cruz I., Van den Brule A.J., Steenbergen R.D., et al. Prevalence of Epstein-Barr virus in oral squamous cell carcinomas, premalignant lesions and normal mucosa — a study using the polymerase chain reaction. Oral Oncol 1997; 33: 182–188PubMedCrossRef
124.
Ghodratnama F., Wray D., Bagg J. Detection of serum antibodies against cytomegalovirus, varicella zoster virus and human herpesvirus 6 in patients with recurrent aphthous stomatitis. J Oral Pathol Med 1999; 28: 12–15PubMedCrossRef
125.
Singh K., Kumar S., Jaiswal M.S., et al. Absence of Helicobacter pylori in oral mucosal lesions. Indian Med Assoc 1998; 96: 177–178
126.
Ficarra G., Flaitz C.M., Gaglioti D., et al. White lichenoid lesions of the buccal mucosa in patients with HIV infection. Oral Surg Oral Med Oral Pathol 1993; 76: 460–466PubMedCrossRef
127.
Ceballos-Salobrena A., Aguirre-Urizar J.M., Bagan-Sebastian J.V. Oral manifestations associated with human immunodeficiency virus infection in a Spanish population. J Oral Pathol Med 1996 Nov; 25(10): 523–526PubMedCrossRef
128.
129.
Gruppo Italiano Studi Epidemiologici In Dermatologia (Gised) Lichen planus and liver diseases: a multicentre case-control study. BMJ 1990; 300: 227–230CrossRef
130.
Powell F.C., Rogers R.S. III, Dickson E.R. Lichen planus and the liver. Hepatology 1991; 13: 609–611PubMedCrossRef
131.
Carrozzo M., Gandolfo S., Carbone M., et al. epatitis C virus infection in Italian patients with oral lichen planus: a prospective case-control study. J Oral Pathol Med 1996; 25: 527–533PubMedCrossRef
132.
Ayala F., Balato N., Tranfaglia A., et al. Oral erosive lichen planus and chronic liver disease. J Am Acad Dermatol 1986; 14; 139–140PubMedCrossRef
133.
Del Olmo J.A., Bagan J.V., Rodrigo J.M., et al. Oral lichen planus and hepatic cirrhosis. Ann Intern Med 1989; 110: 666PubMed
134.
Divano M.C., Parodi A., Rebora A. Lichen planus, liver kidney microsomal (LKM1) antibodies and hepatitis C virus antibodies. Dermatol 1992; 185: 132–133CrossRef
135.
Rebora A., Rongioletti F., Drago F., et al. Lichen planus as a side effect of HBV vaccination. Dermatology 1999; 198: 1–2PubMedCrossRef
136.
Rebora A., Robert E., Rongioletti F. Clinical and laboratory presentation of lichen planus patients with chronic liver disease. J Dermatol Sci 1992; 4: 38–41PubMedCrossRef
137.
Powell F.C., Rogers R.S. Primary biliary cirrhosis, penicillamine and lichen planus. Lancet 1981; ii: 525CrossRef
138.
Graham-Brown R.A.C., Sarkany I., Sherlock S. Lichen planus and primary biliary cirrhosis. Br J Dermatol 1982; 106: 699–703PubMedCrossRef
139.
Powell F.C., Rogers R.S., Dickson E.R. Lichen planus. Primary biliary cirrhosis and penicillamine. Br J Dermatol 1982; 107: 616CrossRef
140.
Oleaga J.M., Gardeazabal J., Sanz De Galdeano C., et al. Generalized lichen planus associated with primary biliary cirrhosis which resolved after liver transplantation. Acta Derm Venereol 1995; 75: 87PubMed
141.
Golding P.J., Smith M., Williams R. Multisystem involvement in chronic liver disease: studies on the incidence and pathogenesis. Am J Med 1973; 55: 772–782PubMedCrossRef
142.
Mobacken H., Nilsson L.A., Olsson R., et al. Incidence of liver disease in chronic lichen planus of the mouth. Acta Derm Venereol 1984; 64: 70–73PubMed
143.
El-Kabir M., Scully C., Porter S., et al. Liver function in UK patients with oral lichen planus. Clin Exp Dermatol 1993; 18: 12–16PubMedCrossRef
144.
Mignogna M.D., LoMuzio L., Favia G., et al. Oral lichen planus and HCV infection; a clinical evaluation of 263 cases. Int J Dermatol 1998; 37: 575–578PubMedCrossRef
145.
Sanchez-Perez J., Castro M., Buezo G.F., et al. Lichen planus and hepatitis C virus: prevalence and clinical presentation of patients with lichen planus and hepatitis C virus infection. Br J Dermatol 1996; 134: 715–719PubMedCrossRef
146.
Bagan J.V., Aguirre J.M., Del Olmo J.A., et al. Oral lichen planus and chronic liver disease: a clinical and morphometric study of the oral lesions in relation to transaminase elevation. Oral Surg Oral Med Oral Pathol 1994; 78: 337–342PubMedCrossRef
147.
Bagan J.V., Ramon C., Gonzales L., et al. Preliminary investigation of the association of oral lichen planus and hepatitis. Oral Surg 1998; 85: 532–536
148.
Bellman B., Reddy R.K., Falanga V. Lichen planus associated with hepatitis C. Lancet 1995; 346: 1234PubMedCrossRef
149.
Chuang T.Y., Stitle L., Brashear R., et al. Hepatitis C virus and lichen planus: A case-control study of 340 patients. J Am Acad Dermatol 1999; 41(5 Pt 1): 787–789PubMedCrossRef
150.
Carrozzo M., Carbone M., Gandolfo S. Lichen planus and lichenoid lesions. In: Porter S.R., Scully C., editors. Innovations and developments in non-invasive orofacial health care. Northwood: Science Reviews, 1996: 97–108
151.
Ingafou M., Porter S.R., Scully C, et al. No evidence for HCV infection or liver disease in British patients with lichen planus. Int J Oral Maxillofac Surg 1998; 27: 65–66PubMedCrossRef
152.
Nagao Y., Sata M., Tanikawa K., et al. Lichen planus and hepatitis C virus in the Northern Kyushu region of Japan. Eur J Clin Invest 1995; 25: 910–914PubMedCrossRef
153.
Jubert C., Pawlotsky J.M., Putget F., et al. Lichen planus and hepatitis C virus-related chronic active hepatitis. Arch Dermatol 1994; 130: 73–76PubMedCrossRef
154.
Nagao Y., Kameyama T., Sata M. Hepatitis C virus RNA detection in oral lichen planus tissue. Am J Gastroenterol 1998; 93: 850PubMedCrossRef
155.
Boyd A.S., Nanney L.B., King Jr L.E. Immunoperoxidase evaluation of lichen planus biopsies for hepatitis C virus. Int J Dermatol 1998; 37: 260–262PubMedCrossRef
156.
Mangia A., Andriuli A., Zanarola P., et al. Lack of hepatitis C virus replication intermediate RNA in diseased skin tissue of chronic hepatitis C patients. J Med Virol 1999; 59: 277–280PubMedCrossRef
157.
Carrozzo M., Gandolfo S., Lodi G., et al. Oral lichen planus in patients infected or non infected with the hepatitis C virus: the role of autommunity. J Oral Pathol Med 1999; 28: 16–19,30PubMedCrossRef
158.
Maibach H.I. Cheilitis: occult allergy to cinnamic aldehyde. Contact Dermatitis 1986; 15: 106–107PubMedCrossRef
159.
Allen C.M., Blozis G1G. Oral mucosal reactions to cinnamon-flavoured chewing gum. J Am Dent Assoc 1988; 116: 664–667PubMed
160.
Lowenthal V., Pisanti S. Oral lichen planus according to the modern medical model. J Oral Med 1984; 39: 224–226
161.
Altman J., Perry H.O. The variations and course of lichen planus. Arch Dermatol 1961; 84: 179–191PubMedCrossRef
162.
Hampf B.G., Malmstrom M.J., Aalberg V.A., et al. Psychiatric disturbance in patients with oral lichen planus. Oral Surg Oral Med Oral Pathol 1987; 63: 429–432PubMedCrossRef
163.
Bergdahl J., Ostman P.-O., Anneroth G., et al. Psychological aspects of patients with oral lichenoid reactions. Acta Odontol Scand 1995; 53: 238–241
164.
Rojo Moreno J.L., Bagan J.V., Rojo Moreno J., et al. Psychologic factors and oral lichen planus. A psychometric evaluation of 100 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 86: 687–691CrossRef
165.
Allen C.M., Beck F.M., Rossie K.M., et al. Relation of stress and anxiety to oral lichen planus. Oral Surg Oral Med Oral Pathol 1986; 61: 44–46PubMedCrossRef
166.
167.
Mccartan B.E. Psychological factors associated with oral lichen planus. J Oral Pathol Med 1995; 24: 273–275PubMedCrossRef
168.
Neumann-Jensen B., Holmstrup P., Pindborg J.J. Smoking habits of 611 patients with oral lichen planus. Oral Surg 1977; 43: 410PubMedCrossRef
169.
Pindborg J.J., Mehta F.S., Daftary D.K., et al. Prevalence of oral lichen planus among 7639 Indian villagers in Kerala, South India. Acta Derm Venereol (Stockh) 1972; 52: 216
170.
Daftary D.K., Bhonsie R.B., Musti R.B., et al. An oral lichen planus-like lesion in Indian betel tobacco chewers. Scand J Dent 1980; 88: 244–245
171.
Macleod R.I., Soames J.V. Lichen sclerosus et atrophicus of the oral mucosa. Br J Oral Maxillofac Surg 1991; 89: 64–65CrossRef
172.
Marren P., Millard P., Chia Y., et al. Mucosal lichen sclerosis/lichen planus overlap syndromes. Br J Dermatol 1994; 131: 118–123PubMedCrossRef
173.
Jaremko W.M., Beutner E.H., Kumar V. Chronic ulcerative stomatitis associated with a specific immunologic marker. J Am Acad Dermatol 1990; 22: 215–220PubMedCrossRef
174.
Beutner E.H., Chorzelski T.P., Parodi A. Ten cases of chronic ulcerative stomatitis with stratified epithelium-specific antinuclear antibody. J Am Acad Dermatol 1991; 24: 781–782PubMedCrossRef
175.
Church L.F., Schlosser R.H. Chronic ulcerative stomatitis associated with stratified epithelial specific antinuclear antibody. Oral Surg 1992; 73: 579–582PubMedCrossRef
176.
Cohen D.M., Bhattacharyya I., Zunt S.L., et al. Linear IgA disease histopathologically and clinically masquerading as lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 88: 196–201PubMedCrossRef
177.
Holmstrup P., Schiotz A.W., Hyug D., et al. Effect of dental plaque control on gingival lichen planus. Oral Surg Oral Med Oral Pathol 1990; 69: 585–590PubMedCrossRef
178.
Erpenstein H. Periodontal and prosthetic treatment in patients with oral lichen planus. J Clin Periodontol 1985; 12: 104–112PubMedCrossRef
179.
180.
Ostman P.O., Anneroth G., Skoglund A. Amalgam-associated oral lichenoid reactions. Clinical and histologic changes after removal of amalgam fillings. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996; 81: 459–465PubMedCrossRef
181.
Stankler L., Ewan S.W. The effects of experimental skin damage in patients with lichen planus. A preliminary communication. Br J Dermatol 1974; 90: 25–28PubMedCrossRef
182.
Krogh P., Hald B., Holmstrup P. Possible mycological etiology of oral mucosal cancer: catalytic potential of infecting Candida albicans and other yeasts in production of N-nitrosobenzylmethylamine. Carcinogenesis 1987; 8: 1543–1548PubMedCrossRef
183.
Mumford P.B., Morgan J.K. The use of cortisone in lichen planus. Br J Dermatol 1956; 68: 258–260PubMedCrossRef
184.
Randell S., Cohen L. Erosive lichen planus. Management of oral lesions with intralesional corticosteroid injections. J Oral Med 1974; 29: 88–91PubMed
185.
Itin P., Surger C., Buchner S. Lack of effect after local treatment with a new cyclosporin formulation in recalcitrant erosive oral lichen planus. Dermatol 1992; 185: 262–265CrossRef
186.
Becherel P.-A., Chosidow O., Boisnic S., et al. Topical cyclosporine in the treatment of oral and vulvar erosive lichen planus: a blood level monitoring study. Arch Dermatol 1995; 131: 495–496PubMedCrossRef
187.
Eisen D., Ellis C.N., Duell E.A., et al. Effect of topical cyclosporine rinse on oral lichen planus: a double-blind analysis. N Engl J Med 1990; 323: 290–294PubMedCrossRef
188.
Ho V.C., Gupta A.K., Ellis C.N., et al. Treatment of severe lichen planus with cyclosporine. J Am Acad Dermatol 1990; 22: 64–68PubMedCrossRef
189.
Ho V.C., Conklin R.J. Effect of topical cyclosporine rinse on oral lichen planus. N Engl J Med 1991; 325: 435PubMedCrossRef
190.
Hersle K., Mobacken H., Sloberg K., et al. Severe oral lichen planus: treatment with an aromatic retinoid (etretinate). Br J Dermatol 1982; 106: 77–80PubMedCrossRef
191.
Sloberg K., Hersle K., Mobacken H., et al. Topical tretinoin therapy and oral lichen planus. Arch Dermatol 1979; 115: 716–718PubMedCrossRef
192.
Sloberg K., Hersle K., Mobacken H., et al. Severe oral lichen planus: remission and maintenance with vitamin A analogues. J Oral Pathol 1983; 12: 473–477PubMedCrossRef
193.
Ferguson M.M., Simpson N.B., Hammersley N. The treatment of erosive lichen planus with a retinoid-etretinate. Oral Surg Oral Med Oral Pathol 1984; 58: 283–287PubMedCrossRef
194.
195.
Staus M.E., Bergfeld W.F. Treatment of oral lichen planus with low-dose isotretinoin. J Am Acad Dermatol 1984; 11: 527–528CrossRef
196.
Zegarelli D.J. Treatment of oral lichen planus with topical vitamin A acid. J Oral Med 1984; 39: 186–191PubMed
197.
Woo T.Y. Systemic isotretinoin treatment of oral and cutaneous lichen planus. Cutis 1985; 35: 385–393PubMed
198.
Eisen D. Hydroxychloroquine sulfate (Plaquenil) improves oral lichen planus: an open trial. J Am Acad Dermatol 1993; 28: 609–612PubMedCrossRef
199.
Cribier B., Frances C., Chosidow O. Treatment of lichen planus. An evidencedbased medicine analysis of efficacy. Arch Dermatol 1998; 134: 1521–15230PubMedCrossRef
200.
Voute A.B., Schulten E.A., Langendijk P.N., et al. Fluocinonide in an adhesive base for treatment of oral lichen planus. A double-blind, placebo-controlled clinical study. Oral Surg Oral Med Oral Pathol 1993; 75: 181–185PubMedCrossRef
201.
202.
Eisen D. The vulvovagina-gingival syndrome of lichen planus. Arch Dermatol 1994; 130: 1379–1382PubMedCrossRef
203.
Zegarelli D. Topical intralesional steroid therapy of oral lichen planus. NYS Dent J 1980; 46: 432
204.
Lozada F., Silverman J. Topically applied fluocinonide in an adhesive base in the treatment of oral vesiculoerosive diseases. Arch Dermatol 1980; 116: 190–201CrossRef
205.
Thongprasom K., Luangjarmekorn L., Sererat T., et al. Relative efficacy of fluocinolone acetonide compared with triamcinolone acetonide in treatment of oral lichen planus. J Oral Pathol Med 1992; 21: 456–458PubMedCrossRef
206.
Buajeeb W., Pobrurksa C., Kraivphan P. Efficacy of fluocinolone acetonide gel in the treatment of oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000; 89: 42–45PubMedCrossRef
207.
Holbrook W.P., Kristmundsdottir T., Loftsson T., Aqueous hydrocortisone mouthwash solution: clinical evaluation. Acta Odontol Scand 1998; 56: 157–160PubMedCrossRef
208.
Tyldesley W.R., Harding S.M. Betamethasone valerate aerosol in the treatment of oral lichen planus. Br J Dermatol 1977; 96: 659–662PubMedCrossRef
209.
Greenspan J.S., Yeoman C.M., Harding S.M. Oral lichen planus. A double-blind comparison of treatment with betamethasone valerate aerosol and pellets. Br Dent J 1978; 144: 83–84PubMedCrossRef
210.
Zegarelli E.V., Kutscher A.H., Silvers H.F., et al. Triamcinolone acetonide in the treatment of acute and chronic lesions of the oral mucous membranes. Preliminary report. Oral Surg Oral Med Oral Pathol 1960; 13: 170–175PubMedCrossRef
211.
Zegarelli F., Kutscher A., Mehrhof A. Long-lasting lozenges with triamcinolone acetonide. NYS J Med 1969; 69: 2463
212.
Rushton R.J. Treatment of ulcerative mouth lesions with orabase. Br J Dermatol 1962; 74: 462–464PubMedCrossRef
213.
Deasy P.B., Collins A.E., Burke F.M., et al. In vitro and in vivo evaluation of a bondable compact for the prolonged delivery of triamcinolone acetonide to the oral cavity in patients with lichen planus. Pharmaceut Acta Helv 1989; 64: 279–281
214.
McCartan B.E., Jontell M., Jungell P. Oral Lichen planus and lichenoid reactions. Oral Dis 1997; 3: 43–44
215.
Beckman B.I. Valisone aerosol spray contraindicated in mucous membranes. J Am Acad Dermatol 1981; 4: 233PubMedCrossRef
216.
Roed-Petersen B., Roed-Petersen J. Occlusive treatment of atropic and erosive oral lichen planus with clobetasole proprionate 0.05 % ointment. Tandlaegernes Tidsskr 1992; 1: 4–7PubMed
217.
Lozada-Nur F., Miranda C., Malinski R. Double-blind clinical trial of 0.05 % clobetasol propionate ointment in orabase and 0.0 5% fluocinonide ointment in orabase in the treatment of patients with oral vesiculoerosive diseases. Oral Surg Oral Med Oral Pathol 1994; 77: 598–604PubMedCrossRef
218.
Mokni M., Battikh O., Hamzaoui S., et al. Erosive oral lichen planus and chronic hepatitis C: disappearance of the lichen on treatment with topical clobetasol [letter]. Eur J Dermatol 1996; 6: 323
219.
Plemons J.M., Rees T.D., Zachariak N.Y. Absorption of topical steroid and evaluation of adrenal suppression in patients with erosive lichen planus. Oral Surg Oral Med Oral Pathol 1990; 69: 688–693PubMedCrossRef
220.
Sallay K. Lichen oris kexelese intrafocalisan adott hydrocortison mikrokristaly suspensioval. Fogory Szeml 1969; 62: 257
221.
Sleeper H.R. Intralesional and sublesional injection of triamcinolone acetonide for oral lichen planus. Yale J Biol Med 1967; 40: 164–165PubMed
222.
Zegarelli D.J. Multimodality steroid therapy of erosive and ulcerative oral lichen planus. J Oral Med 1983; 38: 127PubMed
223.
Pelisse M. The vulvo-vaginal-gingival syndrome: a new form of erosive lichen planus. Int J Dermatol 1989; 28: 381–384PubMedCrossRef
224.
Carbone M., Carrozzo M., Castellano S., et al. Systemic corticosteroids therapy of oral vesiculoerosive diseases (OVED). An open trial. Minerva Stomatol 1998; 47: 479–487PubMed
225.
Lozada F., Silverman J., Migliorati C. Adverse side effects associated with prednisone in the treatment of patients with oral inflammatory ulcerative diseases. J Am Dent Assoc 1984; 1091: 269–270
226.
Snyder R.A., Schwartz R.A., Schneider J.S., et al. Intermittent megadose corticosteroid therapy for generalised lichen planus. J Am Acad Dermatol 1982; 6: 1089PubMedCrossRef
227.
Magrin S, Craxi A., Fabiano C., et al. Hepatitis C viremia in chronic liver disease: relationship to interferon or corticosteroid treatment. Hepatology 1994; 19: 273–279PubMedCrossRef
228.
Eisen D., Griffiths C.E.M., Ellis C.N., et al. Cyclosporin wash for oral lichen planus. Lancet 1990; 335: 535–536PubMedCrossRef
229.
Eisen D., Ellis C.N., Voorhees J.J. Topical cyclosporine for oral bullous disorders. J Am Acad Dermatol 1990; 23: 936–937PubMedCrossRef
230.
Frances C., Boisnic S., Etienne S., et al. Effect of the local application of cyclosporine A on chronic erosive lichen planus of the oral cavity. Dermatologica 1988; 177: 194–195PubMedCrossRef
231.
Balato N., De Rosa S., Bordone S., et al. Dermatological application of cyclosporine. Arch Dermatol 1989; 125: 1430–1431PubMedCrossRef
232.
Pacor M.L., Biasi D., Urbani G., et al. The efficacy of cyclosporin for topical use in oral lichen planus. Minerva Stomatol 1994; 43: 129–132PubMed
233.
Harpenau L.A., Plemons J.M., Rees T.D. Effectiveness of a low dose of cyclosporine in the management of patients with oral erosive lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995; 80: 161–167PubMedCrossRef
234.
Epstein J.B., Truelove E.L. Topical cyclosporine in a bioadhesive for treatment of oral lichenoid mucosal reactions: an open label clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996; 82: 532–536PubMedCrossRef
235.
Lopez J., Rosello llabres X. Cyclosporine A, an alternative to the oral lichen planus erosive treatment. Bull Group Int Rech Sci Stomatol Odontol 1995; 38: 33–38
236.
Gombos F., Capello B., Gaeta G.M., et al. La ciclosporina in formulazione bioadesiva nella terapia del lichen planus orale erosivo. Minerva Stomatol 1992; 41: 385–389PubMed
237.
Levell N.J., Munro C.S., Marks J.M. Severe lichen planus clears with very low-dose cyclosporin. Br J Dermatol 1992; 127: 66–67PubMedCrossRef
238.
Levell N.J., Macleod R.I., Marks J.M. Lack of effect of cyclosporin mouthwash in oral lichen planus. Lancet 1991; 337: 796–797PubMedCrossRef
239.
Sieg P., Von Domarus H., Von Zitzewitz V., et al. Topical cyclosporin in oral lichen planus: a controlled, randomized, prospective trial. Br J Dermatol 1995; 132: 790–794PubMedCrossRef
240.
Jungell P., Malmstrom M. Cyclosporin A mouthwash in the treatment of oral lichen planus. Int J Oral Maxillofac Surg 1996; 25: 60–62PubMedCrossRef
241.
Lozada F. Prednisolone and azathioprine in the treatment of patients with vesiculoerosive oral diseases. Oral Surg Oral Med Oral Pathol 1981; 52: 257–60PubMedCrossRef
242.
Lear J.T., English J.S.C. Erosive and generalised lichen planus responsive to azathioprine. Clin Exp Dermatol 1996; 21: 56–57PubMedCrossRef
243.
Sun A., Chiang C.P., Chiou P.S., et al. Immunomodulation by levamisole in patients with recurrently aphthous ulcers or oral lichen planus. J Oral Pathol Med 1994; 4: 172–177CrossRef
244.
Sharps R.S. Lichen planus treated with levamisole. J Cont Educ Dermatol 1978; 17: 32
245.
Lu S.-Y., M. Chen W.-J., Eng H.-L. Dramatic response to levamisole and low-dose prednisolone in 23 patients with oral lichen planus. Oral Surg Oral Med Oral Pathol 1995; 80: 705–709CrossRef
246.
Lu S.Y., Chen W.J., Eng H.L. Response to levamisole and low-dose prednisolone in 41 patients with chronic oral ulcers: a 3-year open clinical trial and follow-up study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 86: 438–445PubMedCrossRef
247.
Sato M., Yoshida H., Yanagawa T., et al. Therapeutic effect of human fibroblast interferon on premalignant lesions arising in the oral mucosa. Int J Oral Surg 1985; 14: 184–194PubMedCrossRef
248.
Pedersen A. IFN-alpha cream in the treatment of oral lichen planus. Oral Dis 1998; 4: 155–156PubMedCrossRef
249.
Doutre M.S., Beylot C., Couzigou P., et al. Lichen planus and virus C hepatitis: disappearance of the lichen under interferon alpha therapy. Dermatology 1992; 184: 229PubMedCrossRef
250.
Hildebrand A., Kolde G., Luger T., et al. Successful treatment of generalized lichen planus with recombinant interferon alfa-2b. J Am Acad Dermatol 1995; 33: 880–883PubMedCrossRef
251.
Nagao Y., Sata M., Suzuki H., et al. Histological improvement of oral Lichen planus in patients with chronic hepatitis C treated with interferon. Gastroenterology 1999; 117: 283–284PubMedCrossRef
252.
Protzer U., Oschsendorf E.R., Leopolder-Ochsendorf A., et al. Exacerbation of lichen planus during interferon alfa-2a therapy for chronic active hepatitis Clin. Gastroenterol 1993; 104: 903–905
253.
Nagao Y., Sata M., Ide T., et al. Development and exacerbation of oral lichen planus during and after interferon therapy for hepatitis C. Eur J Clin Invest 1996; 26: 1171–1174PubMedCrossRef
254.
Schlesinger T.E., Camisa C., Gay J.D., et al. Oral erosive lichen planus with epidermolytic hyperkeratosis during interferon alfa-2b therapy for chronic hepatitis C virus infection. J Am Acad Dermatol 1997; 36: 1023–1025PubMedCrossRef
255.
Areoas J., Velho G.C., Cerqueira R., et al. Lichen planus and chronic hepatitis C: exacerbation of the lichen under interferon-alpha-2a therapy. Eur J Gastroenterol Hepatol 1996; 8: 825–828
256.
Kutting B., Bohm M., Luger T.A., et al. Oropharyngeal lichen planus associated with interferon-alpha treatment for mycosis fungoides: a rare side-effect in the therapy of cutaneous lymphomas. Br J Dermatol 1997; 137: 836–837PubMedCrossRef
257.
Boccia S., Gamberini S., Dalla Libera M. Lichen planus and interferon therapy for hepatitis C. Gastroenterology 1993; 105: 1921–1922PubMed
258.
D’agay-Abensour L, Benamouzig R., De Belilovsky C., et al. Lichen planus during chronic hepatitis C treated with interferon alpha. Gastroenterol Clin Biol 1992; 16: 610–611PubMed
259.
Frider B., Sookoian S., Castano G., et al. Lichen planus, chronic hepatitis C and interferon. Hepatology 1995; 21: 1764–1765PubMedCrossRef
260.
Papini M., Bruni P.L., Bettacchi A., et al. Sudden onset of oral ulcerative lichen in a patient with chronic hepatitis C on treatment with alfa-interferon. Int J Dermatol 1994; 33: 221–222PubMed
261.
Shiohara T., Nickoloff B.J., Moriya N., et al. In vivo effects of interferon-gamma and anti-interferon-gamma antibody on the experimentally induced lichenoid tissue reaction. Br J Dermatol 1988; 119: 199–206PubMedCrossRef
262.
Falk D.K., Latour D.L., King L.E. Dapsone in the treatment of erosive lichen planus. J Am Acad Dermatol 1985; 12: 56–57CrossRef
263.
Beck H.I., Brandup F. Treatment of erosive lichen planus with dapsone. Acta Derm Venereol (Stockh) 1986; 66: 366–367
264.
Matthews R.W., Pinkney R.C., Scully C. The management of desquamative gingivitis with dapsone. Ann Dent 1991; 48: 41–43
265.
Sardella A., Demarosi F., Oltolina A., et al. Efficacy of topical mesalazine compared with clobetasol propionate in treatment of symptomatic oral lichen planus. Oral Dis 1998; 4: 255–259PubMedCrossRef
266.
Alstead E.M., Wilson A.G., Farthing M.J. Lichen planus and mesalazine. J Clin Gastroenterol 1991; 13: 335–337PubMedCrossRef
267.
Hodak E., Yosipovitch G., David M., et al. Low-dose low-molecular-weight heparin (enoxaparin) is beneficial in lichen planus: a preliminary report. J Am Acad Dermatol 1998; 38: 564–568PubMedCrossRef
268.
Stefanidou M.P., Ioannidou D.J., Panayaiotiodes J.G., et al. Low molecular weight heparin: a novel alternative therapeutic approach for lichen planus. Br J Dermatol 1999; 141: 1040–1045PubMedCrossRef
269.
Meingassner J.G., Stutz A. Immunosuppressive macrolides of the type FK506: a novel class of topical agents for treatment of skin diseases? J Invest Dermatol 1992; 98: 851–855PubMedCrossRef
270.
Lauerma A.I., Mainbach HI. Topical FK506: clinical potential or laboratory curiosity? Dermatology 1994; 188: 173–176PubMedCrossRef
271.
Vente C., Reich K., Rupprecht R., et al. Erosive mucosal lichen planus: response to topical treatment with tacrolimus. Br J Dermatol 1999; 140: 338–342PubMedCrossRef
272.
Dereure O., Basset-Seguin N., Guilhou J.J. Erosive lichen planus: dramatic response to thalidomide. Arch Dermatol 1996; 132: 1392–1393PubMedCrossRef
273.
Bez C., Lodi G., Sardella A., et al. Oral lichenoid lesions after thalidomide treatment. Dermatology 1999; 199(2): 195PubMedCrossRef
274.
Nagao Y., Sata M., Suzuki H., et al. Effectiveness of glycyrrhizin for oral lichen planus in patients with chronic HCV infection. J Gastroenterol 1996; 31: 691–695PubMedCrossRef
275.
Nagao Y., Sata M., Tanikawa K., et al. A case of oral lichen planus with chronic hepatitis C successfully treated by glycyrrhizin. J Jpn Assoc Infect Dis 1995; 69: 940–944
276.
Van Rossum T.G., Vulto A.G., de Man R.A., et al. Review article: glycyrrhizin as a potential treatment for chronic hepatitis C. Aliment Pharmacol Ther 1998; 12: 199–205PubMedCrossRef
277.
Boisnic S., Branchet M.C., Pascal F., et al. Tretinoin topique dans le traitment des lichen planus et des leucoplasies de la muqueuse buccal. Ann Dermatol Venereol 1994; 121: 459–463PubMed
278.
Giustina T.A., Stewart J.C.B., Ellis C.E., et al. Topical application of isotretinoin gel improves oral lichen planus. J Arch Dermatol 1986; 22: 534–536CrossRef
279.
Puiatti P., Merlino A., Malvano L. Isotretinoina 0.1 % in lipogel: esperienza terapeutica nel lichen planus delle mucose. G Ital Dermatol Venereol 1988; 123: 125–128PubMed
280.
Buajeeb W., Kraivaphan P., Pobrurksa C. Efficacy of topical retinoic acid compared with topical fluocinolone acetonide in the treatment of oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997; 83: 21–25PubMedCrossRef
281.
Tradati N., Chiesa F., Rossi N., et al. Successful topical treatment of oral lichen planus and leukoplakias with fenretinide (4-HPR). Cancer Lett 1994; 76: 109–111PubMedCrossRef
282.
Gorsky M., Raviv M. Efficacy of etretinate (Tigason) in symptomatic oral lichen planus. Oral Surg Oral Med Oral Pathol 1992; 73: 52–55PubMedCrossRef
283.
Gunther S.H. Vitamin A acid in the treatment of oral lichen planus. Arch Dermatol 1973; 107: 277PubMedCrossRef
284.
Ebner H., Mischer P., Raff M. Lokalbehandlung des Lichen ruber planus der Mundscheimhaut mit Vitamin A Saure. Z Hautkr 1973; 48: 735–740PubMed
285.
Jolly M., Nobile S. Vitamin status of patients with oral lichen planus. Aust Dent J 1977; 22: 446–450PubMedCrossRef
286.
Stuttgen G. Oral vitamin A acid therapy. Acta Derm Venereol 1975; 55: 174–175
287.
Barriere H. Lichen plan buccal: traitment par le retinoide aromatique. Ann Dermatol Venereol 1983; 110: 847–848PubMed
288.
Baudet-Pommel M., Janin-Mercier A., Souteyrand P., et al. Sequential immunopathologic study of oral lichen planus treated with tretinoin and etretinate. Oral Surg Oral Med Oral Pathol 1991; 71: 197–202PubMedCrossRef
289.
Camisa C., Allen C.M. Treatment of oral erosive lichen planus with systemic isotretinoin. Oral Surg Oral Med Oral Pathol 1986; 62: 393–396PubMedCrossRef
290.
Ott F., Bollag W., Geiger J.M. Efficacy of oral low-dose tretinoin (all-trans-retinoic acid) in lichen planus. Dermatology 1996; 192: 334–336PubMedCrossRef
291.
Laurberg G., Geiger J.M., Hjorth N., et al. Treatment of lichen planus with acitretin. J Am Acad Dermatol 1991; 24: 434–437PubMedCrossRef
292.
Vescovi P., Gennari P.U. Lichen planus orale. Orientamenti terapeutici ed esperienza clinica in 71 pazienti. Minerva Stomatol 1996; 45: 501–515PubMed
293.
Samman P.D. Lichen planus: an analysis of 200 cases. Trans St John’s Hosp 1961; 46: 36
294.
Hard S., Holmberg P. Penicillin treatment of lichen ruber planus. Acta Derm Venereol (Stockh) 1954; 34: 72
295.
Ronbeck B.A., Lind P.O., Thrane P.S. Desquamative gingivitis: preliminary observations with tetracycline treatment. Oral Surg Oral Med Oral Pathol 1990; 69: 694–697PubMedCrossRef
296.
Walchner M., Messer G., Salomon N., et al. Topical tetracycline treatment of erosive oral lichen planus. Arch Dermatol 1999; 135: 92–93PubMedCrossRef
297.
Sehgal V.N., Abraham G.J.S., Malik G.B. Griseofulvin therapy in lichen planus. A double-blind control trial. Br J Derm 1972; 87: 383–385CrossRef
298.
Massa M.C., Rogers S., III. Griseofulvin therapy of lichen planus. Acta Derm Venereol 1981; 61: 547–550PubMed
299.
Augdemorte T.B., Devillez R.L., Gieseker D.R. Griseofulvin in the treatment of three cases of oral erosive lichen planus. Oral Surg Oral Med Oral Pathol 1983; 55: 459–462CrossRef
300.
Lamey P.J., Boyle M.A., Simpson N.B., et al. Pilot study of griseofulvin therapy in erosive oral lichen planus. J Oral Med 1987; 42: 233–235
301.
Bagan J.V., Silvestre F.J., Mestre S., et al. Treatment of lichen planus with griseofulvin. Report of seven cases. Oral Surg Oral Med Oral Pathol 1985; 60: 608–610PubMedCrossRef
302.
Matthews R.W., Scully C. Griseofulvin in the treatment of oral lichen planus: adverse drug reactions but little beneficial effect. Ann Dent 1992; 51: 10–11PubMed
303.
Naylor G.D. Treating erosive lichen planus with griseofulvin: a report of four cases. Quintessence Int 1990; 21: 943–947PubMed
304.
De Argila D., Gonzalo A., Pimental J., et al. Isolated lichen planus of the lip successfully treated with chloroquine phosphate. Dermatology 1997; 195: 284–285PubMedCrossRef
305.
Magro C.M., Crowson A.N. Lichenoid and granulomatous dermatitis. Int J Dermatol 2000; 39: 126–133PubMedCrossRef
306.
Bogaert H., Sanchez E. Lichen planus: treatment of thirty cases with systemic and topical phenytoin. Int J Dermatol 1990; 29: 157–158PubMedCrossRef
307.
Tone T., Nishioka K., Kameyama K., et al. Common histopathological process of phenytoin drug eruption. J Dermatol 1992; 19: 27–34PubMed
308.
Jansen C.T., Lehtinen R., Happonen R.R., et al. Health PUVA: new treatment for recalcitrant oral lichen planus. Photodermatology 1987; 4: 165–166PubMed
309.
Narwutsh M., Dietz H., Schultz S., et al. PUVA-Therapie bei Lichen ruber oralis. Eine klinische histologishe Studie. Dermatol Monatsschr 1988; 174: 28–38
310.
Lehtinen R., Happonen R.P., Kuusilehto A., et al. Clinical trial of PUVA treatment in oral lichen planus. Proc Finn Dent Soc 1989; 85: 29–33PubMed
311.
Chen H.R. A newly developed method for treatment of oral lichen planus with ultraviolet irradiation. J Formosan Med Assoc 1968; 88: 248–252
312.
Lundquist G., Forsgren H., Gajecki M., et al. Photochemotherapy of oral lichen planus. A controlled study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995; 79: 554–558PubMedCrossRef
313.
Yoke P.C., Machin D. Photochemotherapy of oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 85: 2–4PubMedCrossRef
314.
Kuusilehto A., Lehtinen R., Happonen R.P., et al. An open clinical trial of a new mouth-PUVA variant in the treatment of oral lichenoid lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997; 84: 502–505PubMedCrossRef
315.
Lehtinen R., Happonen R.-P., Kuusilehto A., et al. A clinical trial of PUVA treatment in oral lichen planus. Int J Oral Maxillofac Surg 1988; 17: 84–86CrossRef
316.
Lindelof B., Sigurgersson B., Tegner E., et al. PUVA and cancer: a large scale epidemiologic study. Lancet 1991; 338: 91–93PubMedCrossRef
317.
Dupre A., Carrere S., Launais B., et al. Lichen planus with photosensitization following pyritinol and PUVA therapy. Ann Dermatol Venereol 1980; 107: 557–559PubMed
318.
Harrist T.J., Pathak M.A., Mosher D.B., et al. Chronic cutaneous effect of long-term psoralen and ultraviolet radiation therapy in patients with vitiligo. Natl Cancer Inst Monogr 1984; 66: 191–196PubMed
319.
Becherel P.A., Bussel A., Chosidow O., et al. Extracorporeal photochemotherapy for chronic erosive lichen planus. Lancet 1998 14; 351: 805PubMedCrossRef
320.
Gerber M., Gmeinhart B., Volc-Platzer B., et al. Complete remission of lichen-planus- like-graft-versus-host disease (GVDH) with extracorporeal photochemotherapy (ECP). Bone Marrow Transplant 1997; 19: 517–519PubMedCrossRef
321.
Emslie E.S., Hardman F.G. The surgical treatment of oral lichen planus. Trans St John’s Hosp Dermatol Soc 1970; 56: 43–44
322.
Vedtofte P., Holmstrup P., Hansen E.H., et al. Surgical treatment of premalignant lesions of the oral mucosa. Int J Oral Maxillofac Surg 1987; 16: 656–664PubMedCrossRef
323.
Malmstrom M., Leikomaa H. Experience with cryosurgery in the treatment of oral lesions. Proc Finn Dent Soc 1980; 76: 117–123PubMed
324.
Loitz G.A., O’Leary J.P. Erosive lichen planus of the tongue treated with cryosurgery. J Oral Maxillofac Surg 1986; 44: 580–582PubMedCrossRef
325.
Frame J.W., Das Gupta A.R., Dalton G.A., et al. Use of the carbon dioxide laser in the management of premalignant lesions of the oral mucosa. J Laryngol Otol 1984; 98: 1251–12560PubMedCrossRef
326.
Horch H., Gerlach K.L., Schaefer H.E. CO2 laser surgery of oral premalignant lesions. Oral Maxillofac Surg 1986; 15: 19–24CrossRef
327.
Loh H.S. A clinical investigation of the management of oral lichen planus with CO 2 laser surgery. J Clin Laser Med Surg 1992; 10: 445–449PubMed
328.
Luomanen M. Experience with a carbon dioxide laser for removal of benign oral soft-tissue lesions. Proc Finn Dent Soc 1992; 88: 49–55PubMed
329.
Tal H., Rafkin B. Cryosurgical treatment of gingival lichen planus: report of a case. J Am Dent Assoc 1986; 113: 629–631PubMed
330.
Hovick C.I, Kalkwarf K.L. Treatment of localised oral erosive lichen planus lesions with free soft tissue grafts. Periodont Case Rep 1987; 9: 21–24PubMed
331.
Katz J., Goultschin J., Benoliel R., et al. Lichen planus evoked by periodontal surgery. J Clin Periodontol 1988; 15: 263–265PubMedCrossRef
332.
Sun M., Qian D.H., Chen Y.H. Effect of diethyldithiocarbamate on interleukin 2 production of patients with oral lichen planus and its clinical therapeutic efficacy. Chung Kuo Yao Li Hsueh Pao 1991; 12: 378–380
333.
Kupriianova T.A., Markov B.P., Vilkova L.A., et al. The use of a permanent magnetic field in the combined treatment of lichen ruber planus of the oral mucosa. Stomatologiia (Mosk)(VIM) 1989; 68: 33–34
334.
Maksimovskaia L.N., Barashkov G.N., Trestov N.G. The methods of modern reflexotherapy in the combined treatment of patients with erosive-ulcerative processes of the oral mucosa. Stomatologiia (Mosk) 1991; 4: 36–37
335.
Nisengard R.J., Rogers R.S. The treatment of desquamative gingival lesions. J Periodontol 1987; 58: 167–172PubMedCrossRef
336.
Wray D., McCord J.F. Labial veneers in the management of desquamative gingivitis. Oral Surg Oral Med Oral Pathol 1987; 64: 41–42PubMedCrossRef
337.
Bollag W., Ott F. Treatment of lichen planus with temarotene. Lancet 1989; ii: 974CrossRef
338.
Porter S.R., Scully C., Eveson J.W. The efficacy of topical cyclosporin in the management of desquamative gingivitis due to lichen planus. Lancet 1994; ii: 753
339.
Tamizi M., Moayedi M. Treatment of gingival lichen planus with a free gingival graft: a case report. Quintessence Int 1992; 23: 249–251PubMed
Metadaten
Titel
Management of Oral Lichen Planus
verfasst von
Professor Crispian Scully
Drore Eisen
Marco Carrozzo
Publikationsdatum
01.09.2000
Verlag
Springer International Publishing
Erschienen in
American Journal of Clinical Dermatology / Ausgabe 5/2000
Print ISSN: 1175-0561
Elektronische ISSN: 1179-1888
DOI
https://doi.org/10.2165/00128071-200001050-00004

Weitere Artikel der Ausgabe 5/2000

American Journal of Clinical Dermatology 5/2000 Zur Ausgabe

Review Article

Fixed Drug Eruptions

Adis New Drug Profile

Alitretinoin

Adis New Drug Profile

Alitretinoin

Disease Management

Management of Facial Hyperpigmentation

Review Article

Advances in Wound Care and Healing Technology

Adis New Drug Profile

Alitretinoin

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Dermatologie

Studienlage spricht für Isotretinoin zur Rosazea-Therapie

23.05.2024 Rosazea Nachrichten

Isotretinoin wird off-label zur Behandlung von Rosazea eingesetzt. Wie solide die Evidenz dafür ist, wurde jetzt in einem systematischen Review überprüft.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Riesenzellarteriitis: 15% der Patienten sind von okkulter Form betroffen

16.05.2024 Riesenzellarteriitis Nachrichten

In einer retrospektiven Untersuchung haben Forschende aus Belgien und den Niederlanden die okkulte Form der Riesenzellarteriitis genauer unter die Lupe genommen. In puncto Therapie und Rezidivraten stellten sie keinen sehr großen Unterschied zu Erkrankten mit kranialen Symptomen fest.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise